tiprankstipranks
Advertisement

INTF - ETF AI Analysis

Compare

Top Page

INTF

iShares MSCI Intl Multifactor ETF (INTF)

Rating:65Neutral
Price Target:
INTF, the iShares MSCI Intl Multifactor ETF, earns a solid overall rating thanks to its focus on financially strong global companies like Novartis and AstraZeneca, which bring robust profitability, positive earnings sentiment, and strategic growth to the portfolio. Large positions in banks such as HSBC and Royal Bank of Canada further support the fund with reasonable valuations and stable performance, while some holdings like BHP and Roche introduce short-term risks through bearish momentum or potential overvaluation. The main risk factor is the ETF’s concentration in a handful of major international financial and healthcare names, which can increase sensitivity to sector-specific news and market swings.
Positive Factors
Strong Overall Performance
The ETF has shown strong year-to-date and recent short-term performance, indicating solid momentum in its strategy.
Leading Holdings Performing Well
Several of the largest positions, including ASML, major banks, and industrial names, have delivered strong gains, supporting the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries and sectors, which helps reduce the impact of weakness in any single market or industry.
Negative Factors
Heavy Country Concentration
Japan and a few other markets make up a large share of the portfolio, which can increase risk if those economies or markets face setbacks.
Mixed Performance Among Top Holdings
While many top holdings are strong, some large positions like Roche and Nestlé have shown relatively weak gains, which can drag on overall results.
Exposure to Financial Sector Cycles
With significant weight in financial companies, the ETF can be sensitive to interest rate changes and banking sector stress.

INTF vs. SPDR S&P 500 ETF (SPY)

INTF Summary

The iShares MSCI Intl Multifactor ETF (INTF) is a fund that follows the STOXX International Equity Factor index, giving you broad exposure to stocks outside the U.S. It invests in many countries like Japan, the UK, and Europe, and spreads money across different sectors such as financials, industrials, and technology. Well-known companies in the fund include ASML and Nestlé. This ETF may appeal to investors who want global diversification with a rules-based approach that looks for traits like strong quality and reasonable prices. A key risk is that international stocks can be volatile and will rise and fall with global markets and currencies.
How much will it cost me?The iShares MSCI Intl Multifactor ETF (INTF) has an expense ratio of 0.16%, which means you’ll pay $1.60 per year for every $1,000 invested. This is lower than average because it’s passively managed, focusing on tracking a multifactor index rather than active stock selection.
What would affect this ETF?The iShares MSCI Intl Multifactor ETF (INTF) could benefit from growth in developed markets outside the U.S., especially if sectors like financials and technology perform well, as they make up a significant portion of the fund. However, challenges such as rising interest rates or economic slowdowns in these regions could negatively impact key holdings like Novartis and ASML, as well as broader sector performance. Regulatory changes or geopolitical tensions in developed markets may also influence the ETF's future returns.

INTF Top 10 Holdings

INTF leans heavily on international financial powerhouses like Mitsubishi UFJ, Mizuho, HSBC, and Royal Bank of Canada, which have been rising and effectively steering the fund’s performance. Industrial name ABB and miner BHP are also adding some punch, despite ABB’s recent wobble. On the flip side, consumer staple giant Nestlé has been lagging, acting more like a brake than an engine. With ASML providing a steady tech tilt and big weights in financials and industrials across developed markets outside the U.S., the ETF is clearly a global, ex-U.S. story driven by banks and cyclicals.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.34%$84.91M€547.84B135.43%
76
Outperform
Novartis AG2.08%$75.44MCHF231.75B31.63%
80
Outperform
Royal Bank Of Canada1.21%$43.96M$290.61B62.00%
75
Outperform
HSBC Holdings1.20%$43.47M£270.81B72.84%
80
Outperform
Roche Holding AG1.07%$38.75M$348.49B38.24%
73
Outperform
ABB Ltd1.05%$38.01Mkr1.68T47.79%
78
Outperform
Mitsubishi UFJ Financial Group1.05%$37.95M¥39.93T62.91%
76
Outperform
Nestlé SA0.94%$33.99MCHF208.38B11.94%
71
Outperform
BHP Group Ltd0.92%$33.41MAU$306.42B62.45%
68
Neutral
Mizuho Financial Group0.91%$33.01M¥19.92T69.56%
77
Outperform

INTF Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
41.14
Positive
100DMA
40.37
Positive
200DMA
38.94
Positive
Market Momentum
MACD
0.40
Negative
RSI
63.85
Neutral
STOCH
91.06
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For INTF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 41.58, equal to the 50-day MA of 41.14, and equal to the 200-day MA of 38.94, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 63.85 is Neutral, neither overbought nor oversold. The STOCH value of 91.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INTF.

INTF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$3.71B0.16%
65
Neutral
$5.99B0.25%
66
Neutral
$5.49B0.40%
68
Neutral
$4.16B0.30%
69
Neutral
$4.09B0.25%
68
Neutral
$2.89B0.43%
60
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
INTF
iShares MSCI Intl Multifactor ETF
42.63
9.00
26.76%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
LVHI
Legg Mason International Low Volatility High Dividend ETF
IMTM
iShares MSCI Intl Momentum Factor ETF
IDMO
Invesco S&P International Developed Momentum ETF
PXF
Invesco FTSE RAFI Developed Markets ex-U.S. ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement